UvA-DARE is a service provided by the library of the University of Amsterdam (http://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Correlation of diagnostic breast imaging data and pathology : application to diagnosisand treatmentDeurloo, E.E.

Link to publication

Citation for published version (APA):Deurloo, E. E. (2005). Correlation of diagnostic breast imaging data and pathology : application to diagnosis andtreatment s.l.: s.n.

General rightsIt is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s),other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulationsIf you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, statingyour reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Askthe Library: http://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam,The Netherlands. You will be contacted as soon as possible.

Download date: 30 May 2018

References s

References s

1.. Research Committee of the Netherlands Cancer Registry. Incidence of cancer in the Netherlandss 1999/2000. 2003.

2.. Zonderland HM, Coerkamp EG, Hermans J, van de Vijver MJ, van Voorthuisen AE. Diagnosiss of breast cancer: contribution of US as an adjunct to mammography. Radio-logyy 1999; 213:413-422

3.. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, andd family history on the sensitivity of first screening mammography. JAMA 1996; 276:33-38 8

4.. Stomper PC, D'Souza DJ, DiNitto PA, Arredondo MA. Analysis of parenchymal den-sityy on mammograms in 1353 women 25-79 years old. AJR Am J Roentgenol 1996; 167:1261-1265 5

5.. Lehman CD, White E, Peacock S, Drucker MJ, Urban N. Effect of age and breast density onn screening mammograms with false- positive findings. AJR Am J Roentgenol 1999; 173:1651-1655 5

6.. Peer PG, Verbeek AL, Straatman H, Hendriks JH, Holland R. Age-specific sensitivities off mammographic screening for breast cancer. Breast Cancer Res Treat 1996; 38:153-160 0

7.. Kolb TM, Lichy J, Newhousee JH. Occult cancer in women with dense breasts: detec-tionn with screening US-diagnostic yield and tumor characteristics. Radiology 1998; 207:191-199 9

8.. Buchberger W, Niehoff A, Obrist R DeKoekkoek-Doll P, Dunser M. Clinically and mammographicallyy occult breast lesions: detection and classification with high-resolu-tionn sonography. Semin Ultrasound CT MR 2000; 21:325-336

9.. Viehweg P, Paprosch I, Strassinopoulou M, Heywang-Kobrunner SH. Contrast-enhan-cedd magnetic resonance imaging of the breast: interpretation guidelines. Top Magn Resonn Imaging 1998; 9:17-43

10.. Verkooijen HM, Peeters PH, Buskens E, et al. Diagnostic accuracy of large-core needle biopsyy for nonpalpable breast disease: a meta-analysis. Br J Cancer 2000; 82:1017-1021 1

11.. Parker SH, Burbank F, Jackman RJ, et al. Percutaneous large-core breast biopsy: a multi-institutionall study. Radiology 1994; 193:359-364

12.. Nguyen M, McCombs MM, Ghandehari S, et al. An update on core needle biopsy for radiologicallyy detected breast lesions. Cancer 1996; 78:2340-2345

13.. Liberman L, Dershaw DD, Rosen PP, Abramson AF, Deutch BM, Hann LE. Stereotaxic 14-gaugee breast biopsy: how many core biopsy specimens are needed? Radiology 1994; 192:793-795 5

14.. Mainiero MB, Philpotts LE, Lee CH, Lange RC, Carter D, Tocino I. Stereotaxic core needlee biopsy of breast microcalcifications: correlation of target accuracy and diagnosis withh lesion size. Radiology 1996; 198:665-669

15.. Brenner RJ, Fajardo L, Fisher PR, et al. Percutaneous core biopsy of the breast: effect of operatorr experience and number of samples on diagnostic accuracy. AJR Am J Roent-genoll 1996; 166:341-346

16.. Heywang SH, Hahn D, Schmidt H, et al. MR imaging of the breast using gadolinium-DTPA.. J Comput Assist Tomogr 1986; 10:199-204

17.. Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W. MR imaging off the breast with Gd-DTPA: use and limitations. Radiology 1989; 171:95-103

18.. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and wit-houtt Gd- DTPA. Preliminary observations. Radiology 1989; 170:681-686

19.. Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT. Breast disease: tissue charac-terizationn with Gd-DTPA enhancement profiles. Radiology 1990; 174:491-494

20.. Gribbestad IS, NUsen G, Fjosne H, et al. Contrast-enhanced magnetic resonance ima-gingg of the breast. Acta Oncol 1992; 31:833-842

21.. Lee CH, Smith RC, Levine JA, Troiano RN, Tocino I. Clinical usefulness of MR imaging off the breast in the evaluation of the problematic mammogram. AJR Am J Roentgenol 1999;; 173:1323-1329

22.. Flickinger FW, Allison JD, Sherry RM, Wright JC. Differentiation of benign from malignantt breast masses by time- intensity evaluation of contrast enhanced MRI. Magn Resonn Imaging 1993; 11:617-620

23.. Gribbestad IS, Nilsen G, Fjosne HE, Kvinnsland S, Haugen OA, Rinck PA. Comparative signall intensity measurements in dynamic gadolinium- enhanced MR mammography. JJ Magn Reson Imaging 1994; 4:477-480

24.. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions withh a gadolinium- enhanced TurboFLASH subtraction technique. Radiology 1994; 193:777-781 1

25.. Stomper PC, Herman S, Klippenstein DL, et al. Suspect breast lesions: findings at dyna-micc gadolinium-enhanced MR imaging correlated with mammographic and patholo-gicc features. Radiology 1995; 197:387-395

26.. Kelcz F, Santyr GE, Cron GO, Mongin SJ. Application of a quantitative model to dif-ferentiatee benign from malignant breast lesions detected by dynamic, gadolinium-enhancedd MRI. J Magn Reson Imaging 1996; 6:743-752

27.. Sherif H, Mahfouz AE, Oellinger H, et al. Peripheral washout sign on contrast-enhan-cedd MR images of the breast. Radiology 1997; 205:209-213

28.. Mussurakis S, Buckley DL, Horsman A. Dynamic MRI of invasive breast cancer: assess-mentt of three region-of- interest analysis methods. J Comput Assist Tomogr 1997; 21:431-438 8

29.. Mussurakis S, Gibbs P, Horsman A. Primary breast abnormalities: selective pixel sam-plingg on dynamic gadolinium-enhanced MR images. Radiology 1998; 206:465-473

30.. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic con-trast-enhancedd T(l)-weighted MRI of a diffusable tracer: standardized quantities and symbols.. J Magn Reson Imaging 1999; 10:223-232

References s 149 9

31.. Liney GP, Gibbs P, Hayes C, Leach MO, Turnbull LW. Dynamic contrast-enhanced MRI inn the differentiation of breast tumors: user-defined versus semi-automated region-of-interestt analysis. J Magn Reson Imaging 1999; 10:945-949

32.. Kuhl CK, Mielcareckk P, Klaschik S, et al. Dynamic breast MR imaging: are signal inten-sityy time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-110 0

33.. Issa B, Buckley DL, Turnbull LW. Heterogeneity analysis of Gd-DTPA uptake: impro-vementt in breast lesion differentiation. J Comput Assist Tomogr 1999; 23:615-621

34.. Nunes LW, Schnall MD, Siegelman ES, et al. Diagnostic performance characteristics off architectural features revealed by high spatial-resolution MR imaging of the breast. AJRR Am J Roentgenol 1997; 169:409-415

35.. Nunes LW, Schnall MD, Orel SG, et al. Breast MR imaging: interpretation model. Radi-ologyy 1997; 202:833-841

36.. Mussurakis S, Buckley DL, Drew PJ, et al. Dynamic MR imaging of the breast com-binedd with analysis of contrast agent kinetics in the differentiation of primary breast tumours.. Clin Radiol 1997; 52:516-526

37.. Ikeda O, Yamashita Y, Morishita S, et al. Characterization of breast masses by dynamic enhancedd MR imaging. A logistic regression analysis. Acta Radiol 1999; 40:585-592

38.. Kinkel K, Helbich TH, Esserman LJ, et al. Dynamic high-spatial-resolution MR ima-gingg of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR Amm J Roentgenol 2000; 175:35-43

39.. Orel SG, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging withh radiologic-pathologic correlation. Radiology 1994; 190:485-493

40.. Gilles R, Guinebretiere JM, Lucidarme O, et al. Nonpalpable breast tumors: diagnosis withh contrast-enhanced subtraction dynamic MR imaging. Radiology 1994; 191:625-631 1

41.. Mussurakis S, Buckley DL, Coady AM, Turnbull LW, Horsman A. Observer variability inn the interpretation of contrast enhanced MRI of the breast. Br J Radiol 1996; 69:1009-1016 6

42.. Kuhl CK, Elevelt A, Leutner CC, Gieseke J, Pakos E, Schild HH. Interventional breast MRR imaging: clinical use of a stereotactic localization and biopsy device. Radiology 1997;; 204:667-675

43.. Sinha S, Lucas-Quesada FA, DeBruhl ND, et al. Multifeature analysis of Gd-enhanced MRR images of breast lesions. J Magn Reson Imaging 1997; 7:1016-1026

44.. Gilhuijs KG, Giger ML, Bick U. Computerized analysis of breast lesions in three dimen-sionss using dynamic magnetic-resonance imaging. Med Phys 1998; 25:1647-1654

45.. Penn AI, Bolinger L, Schnall MD, Loew MH. Discrimination of MR images of breast massess with fractal-interpolation function models. Acad Radiol 1999; 6:156-163

46.. Doi K, MacMahon H, Katsuragawa S, Nishikawa RM, Jiang Y. Computer-aided diagno-siss in radiology: potential and pitfalls. Eur J Radiol 1999; 31:97-109

47.. Jiang Y, Nishikawa RM, Schmidt RA, Metz CE, Giger ML, Doi K. Improving breast cancerr diagnosis with computer-aided diagnosis. Acad Radiol 1999; 6:22-33

150 0 References s

48.. Huo Z, Giger ML, Vyborny CJ, Metz CE. Breast cancer: effectiveness of computer-aided diagnosiss observer study with independent database of mammograms. Radiology 2002; 224:560-568 8

49.. Leichter I, Fields S, Nirel R, et al. Improved mammographic interpretation of masses usingg computer-aided diagnosis. Eur Radiol 2000; 10:377-383

50.. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparingg breast-conserving therapy with mastectomy: European Organization for Researchh and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000; 92:1143-1150

51.. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparingg breast-conserving surgery with radical mastectomy for early breast cancer. NN Engl J Med 2002; 347:1227-1232

52.. Hilleren DJ, Andersson IT, Lindholm K, Linnell FS. Invasive lobular carcinoma: mam-mographicc findings in a 10-year experience. Radiology 1991; 178:149-154

53.. Krecke KN, Gisvold JJ. Invasive lobular carcinoma of the breast: mammographic fin-dingss and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol 1993; 161:957-960 0

54.. Davis PL, Staiger MJ, Harris KB, et al. Breast cancer measurements with magnetic reso-nancee imaging, ultrasonography, and mammography. Breast Cancer Res Treat 1996; 37:1-9 9

55.. Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancerr with MR imaging. AJR Am J Roentgenol 1997; 169:417-424

56.. Drew PJ, Chatterjee S, Turnbull LW, et al. Dynamic contrast enhanced magnetic reso-nancee imaging of the breast is superior to triple assessment for the preoperative detec-tionn of multifocal breast cancer. Ann Surg Oncol 1999; 6:599-603

57.. Tan JE, Orel SG, Schnall MD, Schultz DJ, Solin LJ. Role of magnetic resonance imaging andd magnetic resonance imaging-- guided surgery in the evaluation of patients with early-stagee breast cancer for breast conservation treatment. Am J Clin Oncol 1999; 22:414-418 8

58.. Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E. Utilit y of magnetic reso-nancee imaging in the management of breast cancer: evidence for improved preopera-tivee staging. J Clin Oncol 1999; 17:110-119

59.. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhan-cedd MR imaging on the therapeutic approach. Radiology 1999; 213:881-888

60.. Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ. Effect of breast magnetic resonancee imaging on the clinical management of women with early-stage breast carci-noma.. J Clin Oncol 2002; 20:3413-3423

61.. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients withh breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003;; 98:468-473

62.. Fisher B, Bauer M, Wickerham DL, et al. Relation of number of positive axillary nodes too the prognosis of patients with primary breast cancer. An NSABP update. Cancer 1983;52:1551-1557 7

References s 151 1

63.. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survi-vall in 24,740 breast cancer cases. Cancer 1989; 63:181-187

64.. Abner AL, Collins L, Peiro G, et al. Correlation of tumor size and axillary lymph nodee involvement with prognosis in patients with Tl breast carcinoma. Cancer 1998; 83:2502-2508 8

65.. Danforth DN, Jr., Findlay PA, McDonald HD, et al. Complete axillary lymph node dis-sectionn for stage I-II carcinoma of the breast. J Clin Oncol 1986; 4:655-662

66.. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity fromm complete axillary dissection. Br J Cancer 1992; 66:136-138

67.. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dis-sectionn in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349:1864-1867 7

68.. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mappingg of patients with breast cancer. Ann Surg 1998; 227:645-651

69.. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer-a multicenter validationn study. N Engl J Med 1998; 339:941-946

70.. Rutgers EJ, Jansen L, Nieweg OE, de Vries J, Schraffordt Koops H, Kroon BB. Technique off sentinel node biopsy in breast cancer. Eur J Surg Oncol 1998; 24:316-319

71.. Bruneton JN, Caramella E, Hery M, Aubanel D, Manzino JJ, Picard JL. Axillary lymph nodee metastases in breast cancer: preoperative detection with US. Radiology 1986; 158:325-326 6

72.. Pamilo M, Soiva M, Lavast EM. Real-time ultrasound, axillary mammography, and clinicall examination in the detection of axillary lymph node metastases in breast cancer patients.. J Ultrasound Med 1989; 8:115-120

73.. Bonnema J, van Geel AN, van Ooijen B, et al. Ultrasound-guided aspiration biopsy forr detection of nonpalpable axillary node metastases in breast cancer patients: new diagnosticc method. World J Surg 1997; 21:270-274

74.. de Kanter AY, van Eijck CH, van Geel AN, et al. Multicentre study of ultrasonographi-callyy guided axillary node biopsy in patients with breast cancer. Br J Surg 1999; 86:1459-1462 2

75.. Parker SH, Lovin JD, Jobe WE, et al. Stereotactic breast biopsy with a biopsy gun. Radi-ologyy 1990; 176:741-747

76.. Parker SH, Lovin JD, Jobe WE, Burke BJ, Hopper KD, Yakes WF. Nonpalpable breast lesions:: stereotactic automated large-core biopsies. Radiology 1991; 180:403-407

77.. Elvecrog EL, Lechner MC, Nelson MT. Nonpalpable breast lesions: correlation of ste-reotaxicc large-core needle biopsy and surgical biopsy results. Radiology 1993; 188:453-455 5

78.. Schmidt RA. Stereotactic breast biopsy. CA Cancer J Clin 1994; 44:172-191 79.. Morrow M. When can stereotactic core biopsy replace excisional biopsy?--A clinical

perspective.. Breast Cancer Res Treat 1995; 36:1-9 80.. Andreu FJ, Sentis M, Castaner E, et al. The impact of stereotactic large-core needle bio-

psyy in the treatment of patients with nonpalpable breast lesions: a study of diagnostic accuracyy in 510 consecutive cases. Eur Radiol 1998; 8:1468-1474

References s

81.. Verkooijen HM, Peeters PH, Pijnappel RM, Koot VC, Schipper ME, Rinkes IH. Diag-nosticc accuracy of needle-localized open breast biopsy for impalpable breast disease. Br JJ Surg 2000; 87:344-347

82.. Dowlatshahi K, Gent HJ, Schmidt R, Jokich PM, Bibbo M, Sprenger E. Nonpalpable breastt tumors: diagnosis with stereotaxic localization and fine-needle aspiration. Radi-ologyy 1989; 170:427-433

83.. Minonzio G, Campi R, Croce F, Tufarulo L, Rossini G, Del Favero C. [A comparative evaluationn of the centering precision performed with 2 different stereotaxic instru-mentss in nonpalpable breast lesions]. Radiol Med (Torino) 1990; 79:189-190

84.. Liberman L, Dershaw DD, Glassman JR, et al. Analysis of cancers not diagnosed at stereotacticc core breast biopsy. Radiology 1997; 203:151-157

85.. Willison KM. Fundamentals of stereotactic breast biopsy. In: Fajardo L, Willison KM, Pizzutielloo RJ, eds. A comprehensive approach to stereotactic breast biopsy. Boston, MA ,, Blackwell Science, 1996; 13-72.

86.. Kaiser WA, Fischer H, Vagner J, Selig M. Robotic system for biopsy and therapy of breastt lesions in a high-field whole-body magnetic resonance tomography unit. Invest Radioll 2000; 35:513-519

87.. Dowlatshahi K, Fan M, Gould VE, Bloom KJ, Al i A. Stereotactically guided laser the-rapyy of occult breast tumors: work-in-progress report. Arch Surg 2000; 135:1345-1352

88.. Fisher PR. Problems and pitfalls in core biopsy. In: Fajardo L, Willison KM, Pizzutiello RJ,, eds. A comprehensive approach to stereotactic breast biopsy. Boston, MA, Blackwell Science,, 1996; 73-92.

89.. Kopans DB. The mammographic appearance of breast cancer. In: Kopans DB, ed. Breast imaging.. Philadelphia, PA, Lippincott-Raven, 1998; 375-408.

90.. Berg WA, Krebs TL, Campassi C, Magder LS, Sun CC. Evaluation of 14- and 11-gauge directional,, vacuum-assisted biopsy probes and 14-gauge biopsy guns in a breast paren-chymall model. Radiology 1997;205:203-208

91.. Meyer JE, Smith DN, DiPiro PJ, et al. Stereotactic breast biopsy of clustered microcal-cificationss with a directional, vacuum-assisted device. Radiology 1997; 204:575-576

92.. Liberman L, Smolkin JH, Dershaw DD, Morris EA, Abramson AF, Rosen PP. Calcifi-cationn retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy. Radiologyy 1998; 208:251-260

93.. Philpotts LE, Shaheen NA, Carter D, Lange RC, Lee CH. Comparison of rebiopsy rates afterr stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versuss 14-gauge needle and automatic gun. AJR Am J Roentgenol 1999; 172:683-687

94.. Liberman L, Drotman M, Morris EA, et al. Imaging-histologic discordance at percuta-neouss breast biopsy. Cancer 2000; 89:2538-2546

95.. Nisbet AP, Borthwick-Clarke A, Scott N. 11-gauge vacuum assisted directional biopsy off breast calcifications, using upright stereotactic guidance. Eur J Radiol 2000; 36:144-146 6

96.. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroidd hormone study. Am J Hum Genet 1991; 48:232-242

References s 153 3

97.. Easton DF, Bishop DT, Ford D, Crockford GR Genetic linkage analysis in familial breast andd ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Amm J Hum Genet 1993; 52:678-701

98.. Kelcz F, Santyr G. Gadolinium-enhanced breast MRI. Crit Rev Diagn Imaging 1995; 36:287-338 8

99.. Obdeijn IM, Kuijpers TJ, van Dijk R Wiggers T, Oudkerk M. MR lesion detection in a breastt cancer population. J Magn Reson Imaging 1996; 6:849-854

100.. Bone B, Pentek Z, Perbeck L, Veress B. Diagnostic accuracy of mammography and con-trast-enhancedd MR imaging in 238 histologically verified breast lesions. Acta Radiol 1997;; 38:489-496

101.. Heywang-Kobrunner SH, Viehweg P, Heinig A, Kuchler C. Contrast-enhanced MRI of thee breast: accuracy, value, controversies, solutions. Eur J Radiol 1997; 24:94-108

102.. Tilanus-Linthorst MM, Bartels CC, Obdeijn AI, Oudkerk M. Earlier detection of breast cancerr by surveillance of women at familial risk. Eur J Cancer 2000; 36:514-519

103.. Brown J, Smith RC, Lee CH. Incidental enhancing lesions found on mr imaging of the breast.. AJR Am J Roentgenol 2001; 176:1249-1254

104.. Kuhl CK, Schmutzler RK, Leutner CC, et al. Breast MR imaging screening in 192 womenn proved or suspected to be carriers of a breast cancer susceptibility gene: preli-minaryy results. Radiology 2000; 215:267-279

105.. Nunes LW, Schnall MD, Orel SG. Update of breast MR imaging architectural interpre-tationn model. Radiology 2001; 219:484-494

106.. Ikeda DM, Hylton NM, Kinkel K, et al. Development, standardization, and testing of a lexiconn for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magnn Reson Imaging 2001; 13:889-895

107.. Kegelmeyer WP> Jr., Pruneda IM, Bourland PD, Hilli s A, Riggs MW, Nipper ML. Com-puter-aidedd mammographic screening for spiculated lesions. Radiology 1994; 191:331-337 7

108.. Veldkamp WJ, Karssemeijer N, Otten JD, Hendriks JH. Automated classification of clusteredd microcalcifications into malignant and benign types. Med Phys 2000; 27:2600-2608 8

109.. Huo Z, Giger ML, Vyborny CJ, et al. Analysis of spiculation in the computerized clas-sificationn of mammographic masses. Med Phys 1995; 22:1569-1579

110.. Rangayyan RM, El-Faramawy N, Desautels JEL, Alim OA. Discrimination between benignn and malignant breast tumors using a region-based measure of edge profile acu-tance.. Proc. 3rd International Workshop on Digital Mammography. 1st ed. Amster-dam,, The Netherlands, Elsevier Science B.V., 1996; 213-218.

111.. Chan HP, Sahiner B, Helvie MA, et al. Improvement of radiologists' characterization of mammographicc masses by using computer-aided diagnosis: an ROC study. Radiology 1999;212:817-827 7

112.. Friedrich M. MRI of the breast: state of the art. Eur Radiol 1998; 8:707-725 113.. Kuhl CK. MRI of breast tumors. Eur Radiol 2000; 10:46-58

154 4 References s

114.. Gilhuijs KG, Giger ML, Bick U. A method for computerized assessment of tumor extent inn contrast-enhanced MR images of the breast. In: Doi K, MacMahon H, Giger ML, Hoffmannn KR, eds. Computer-Aided Diagnosis in Medical Imaging. 1st ed. Amster-dam,, The Netherlands, Elsevier Science B.V., 1999; 305-310.

115.. Johnson RA, Wichern DW. Discrimination and Classification. In: Conmy SR, ed. App-liedd Multivariate statistical analysis. 3rd ed. Upper Saddle River, NJ, Prentice-Hall, Inc., 1992;; 494-502.

116.. Metz CE. ROC methodology in radiologic imaging. Invest Radiol 1986; 21:720-733 117.. Metz CE, Wang P, Kronman HB. A new approach for testing the significance of dif-

ferencess between ROC curves measured from correlated data. In: Deconink F, ed. Informationn processing in medical imaging. 1st ed. The Hague, The Netherlands 1984; 432-445. .

118.. Shen J, Herman B, Wang P, Kronman HB, Dorfman DD, and Metz CE. LABROC1 programm for the IBM PC [computer program]. Available at: http://www-radiology. uchicago.edu/krl/roc_soft.htm.. 1993

119.. Shen J, Herman B, Kronman HB, Wang P, Dorfman DD, and Metz CE. CLABROC pro-gramm IBM-PC [computer program]. Version 1.2.1. Available at: http://www-radiology. uchicago.edu/krl/roc_soft.htm.. 1993

120.. Heywang-Kobrunner SH, Bick U, Bradley WG, Jr., et al. International investigation of breastt MRI: results of a multicentre study (11 sites) concerning diagnostic parameters forr contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radioll 2001; 11:531-546

121.. Peeters PH, Verbeek AL, Hendriks JH, van Bon MJ. Screening for breast cancer in Nijmegen.. Report of 6 screening rounds, 1975-1986. Int J Cancer 1989; 43:226-230

122.. Otten JD, van Dijck JA, Peer PG, et al. Long term breast cancer screening in Nijmegen, Thee Netherlands: the nine rounds from 1975-92. J Epidemiol Community Health 1996; 50:353-358 8

123.. Fracheboud J, de Koning HJ, Beemsterboer PM, et al. Nation-wide breast cancer scree-ningg in The Netherlands: results of initial and subsequent screening 1990-1995. Natio-nall Evaluation Team for Breast Cancer Screening. Int J Cancer 1998; 75:694-698

124.. Tüanus-Linthorst MM , Obdeijn IM, Bartels KC, de Koning H J, Oudkerk M. First expe-riencess in screening women at high risk for breast cancer with MR imaging. Breast Cancerr Res Treat 2000; 63:53-60

125.. Mussurakis S, Gibbs P, Horsman A. Peripheral enhancement and spatial contrast uptake heterogeneityy of primary breast tumours: quantitative assessment with dynamic MRI. J Computt Assist Tomogr 1998; 22:35-46

126.. Gilles R, Zafrani B, Guinebretiere JM, et al. Ductal carcinoma in situ: MR imaging-histopathologicc correlation. Radiology 1995; 196:415-419

127.. Westerhof JP, Fischer U, Moritz JD, Oestmann JW. MR imaging of mammographically detectedd clustered microcalcifications: is there any value? Radiology 1998; 207:675-681 1

References s 155 5

128.. Armes JE, Egan AJ, Southey MC, et al. The histologic phenotypes of breast carcinoma occurringg before age 40 years in women with and without BRCA1 or BRCA2 germline mutations:: a population-based study. Cancer 1998; 83:2335-2345

129.. Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for thee new millennium. J Magn Reson Imaging 1999; 10:903-907

130.. den Boer JA, Hoenderop RK, Smink J, et al. Pharmacokinetic analysis of Gd-DTPA enhancementt in dynamic three- dimensional MRI of breast lesions. J Magn Reson Ima-gingg 1997; 7:702-715

131.. Gilhuijs KG, Deurloo EE, Muller SH, Peterse JL, Schultze Kool LJ. Breast MR Imaging inn Women at Increased Lifetime Risk of Breast Cancer: Clinical System for Computeri-zedd Assessment of Breast Lesions Initial Results. Radiology 2002; 225:907-916

132.. Liberman L, Morris E A, Dershaw DD, Abramson AF, Tan LK. MR imaging of the ipsi-laterall breast in women with percutaneously proven breast cancer. AJR Am J Roentge-noll 2003; 180:901-910

133.. Liberman L, Morris EA, Kim CM, et al. MR imaging findings in the contralateral breast off women with recently diagnosed breast cancer. AJR Am J Roentgenol 2003; 180:333-341 1

134.. Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patientss with newly diagnosed breast cancer: preliminary results. Radiology 2003; 226:773-778 8

135.. Siegmann KC, Muller-Schimpfle M, Schick F, et al. MR imaging-detected breast lesi-ons:: histopathologic correlation of lesion characteristics and signal intensity data. AJR Amm J Roentgenol 2002; 178:1403-1409

136.. Morris EA, Liberman L, Dershaw DD, et al. Preoperative MR imaging-guided needle localizationn of breast lesions. AJR Am J Roentgenol 2002; 178:1211-1220

137.. Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging: features andd positive predictive value. AJR Am J Roentgenol 2002; 179:171-178

138.. Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging,, mammography, and ultrasound for surveillance of women at high risk for hereditaryy breast cancer. J Clin Oncol 2001; 19:3524-3531

139.. Stoutjesdijk MJ, Boetes C, Jager GJ, et al. Magnetic resonance imaging and mam-mographyy in women with a hereditary risk of breast cancer. J Natl Cancer Inst 2001; 93:1095-1102 2

140.. Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population.. AJR Am J Roentgenol 2003; 181:619-626

141.. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma inn dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancementt and cyclical-phase dependency. Radiology 1997; 203:137-144

142.. Muller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen CD. Menstrual cycle andd age: influence on parenchymal contrast medium enhancement in MR imaging of thee breast. Radiology 1997; 203:145-149

References s

143.. LaTrenta LR, Menell JH, Morris EA, Abramson AF, Dershaw DD, Liberman L. Breast lesionss detected with MR imaging: utilit y and histopathologic importance of identifi-cationn with US. Radiology 2003; 227:856-861

144.. Smith LF, Henry-Tillman R, Mancino AT, et al. Magnetic resonance imaging-guided coree needle biopsy and needle localized excision of occult breast lesions. Am J Surg 2001;; 182:414-418

145.. Kuhl CK, Morakkabati N, Leutner CC, Schmiedel A, Wardelmann E, Schild HH. Mr imaging-guidedd large-core (14-gauge) needle biopsy of small lesions visible at breast mrr imaging alone. Radiology 2001; 220:31 -39

146.. Bedrosian I, Schlencker J, Spitz FR, et al. Magnetic resonance imaging-guided biopsy off mammographically and clinically occult breast lesions. Ann Surg Oncol 2002; 9:457-461 1

147.. Jiang Y, Nishikawa RM, Schmidt RA, Toledano AY, Doi K. Potential of computer-aidedd diagnosis to reduce variability in radiologists' interpretations of mammograms depictingg microcalcifications. Radiology 2001; 220:787-794

148.. Leichter I, Buchbinder S, Bamberger P, Novak B, Fields S, Lederman R. Quantitative characterizationn of mass lesions on digitized mammograms for computer-assisted diagnosis.. Invest Radiol 2000; 35:366-372

149.. Altman DG. Relation between several variables. Practical statistics for medical research. 1st.. ed. Boca Raton, Florida, Chapman 8c Hall / CRC Press, 1990; 325-364.

150.. Kriege M, Brekelmans CT, Boetes C, et al. MRI screening for breast cancer in women withh high familial risk (Abstract). Eur J Cancer 2002; 38, Supplement 3:S51-

151.. Schnall MD, Ikeda DM. Lesion Diagnosis Working Group Report. J Magn Reson Ima-gingg 1999; 10:982-990

152.. Obuchowski NA. Multireader receiver operating characteristic studies: a comparison off study designs. Acad Radiol 1995; 2:709-716

153.. Metz, C. E. and Pan, X. PROPROC program for the IBM PC [computer program]. Availablee at: http://www-radiology.uchicago.edu/krl/roc_soft.htm. 2002

154.. Shen J, Wang P, Kronman HB, and Metz CE. ROCKFIT program for the IBM PC. [computerr program]. Available at: http://www-radiology.uchicago.edu/krl/roc_soft. htm.. 2002

155.. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlatedd receiver operating characteristic curves: a nonparametric approach. Biome-tricss 1988;44:837-845

156.. "American College of Radiology (ACR) Breast Imaging Reporting and Data System Atlass (BI-RADS* Atlas)" 2003

157.. Gur D. ROC-type Assessments of Medical Imaging and CAD Technologies: A Perspec-tive.. Acad Radiol 2003; 10:402-403

158.. Rutter CM, Taplin S. Asssessing mammographers' accuracy: a comparison of clinical andd test performance. J Clin Epidemiol 2000; 53:443-450

159.. Kurtz JM, Jacquemier J, Amalric R, et al. Breast-conserving therapy for macroscopi-callyy multiple cancers. Ann Surg 1990; 212:38-44

References s l r > ? ?

160.. Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancerr with standard radiotherapy with or without additional radiation. N Engl J Med 2001;345:1378-1387 7

161.. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, Tl-2 breastt carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985;; 56:979-990

162.. Baum F, Fischer U, Vosshenrich R, Grabbe E. Classification of hypervascularized lesi-onss in CE MR imaging of the breast. Eur Radiol 2002; 12:1087-1092

163.. Deurloo EE, Muller SH, Peterse JL, Besnard APE, Gilhuijs KGA. Clinically and mam-mographicallyy occult breast lesions at MR imaging: potential impact of computerized assessmentt on clinical reading. Radiology March 2005. In Press

164.. Kearney TJ, Morrow M. Effect of reexcision on the success of breast-conserving sur-gery.. Ann Surg Oncol 1995; 2:303-307

165.. Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical marginn status in long-term results of breast conservation. Cancer 1995; 76:259-267

166.. Harris JR, Botnick L, Bloomer WD, ChafTey JT, Hellman S. Primary radiation therapy forr early breast cancer: the experience at The Joint Center for Radiation Therapy. Int J Radiatt Oncol Biol Phys 1981; 7:1549-1552

167.. Zafrani B, Vielh P, Fourquet A, et al. Conservative treatment of early breast cancer: prognosticc value of the ductal in situ component and other pathological variables on locall control and survival. Long-term results. Eur J Cancer Clin Oncol 1989; 25:1645-1650 0

168.. Veronesi U, Salvador! B, Luini A, et al. Breast conservation is a safe method in patients withh small cancer of the breast. Long-term results of three randomised trials on 1,973 patients.. Eur J Cancer 1995; 31 A: 1574-1579

169.. Vrieling C, Collette L, Fourquet A, et al. The influence of patient, tumor and treatment factorss on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs.. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiotherr Oncol 2000; 55:219-232

170.. Tartter PI, Kaplan J, Bleiweiss I, et al. Lumpectomy margins, reexcision, and local recur-rencee of breast cancer. Am J Surg 2000; 179:81-85

171.. Schnitt SJ, Connolly JL, Khettry U, et al. Pathologic findings on reexcision of the pri-maryy site in breast cancer patients considered for treatment by primary radiation the-rapy.. Cancer 1987; 59:675-681

172.. Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal com-ponentt following a limited excision correlates with prominent residual disease in the remainderr of the breast. J Clin Oncol 1990; 8:113-118

173.. Faverly DR, Hendriks JH, Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologicc characteristics, and surgical margin requirements. Cancer 2001; 91:647-659 9

174.. Boetes C, Mus RD, Holland R, et al. Breast tumors: comparative accuracy of MR ima-gingg relative to mammography and US for demonstrating extent. Radiology 1995; 197:743-747 7

158 8 References s

175.. Weinstein SP, Orel SG, Heller R, et al. MR Imaging of the Breast in Patients with Inva-sivee Lobular Carcinoma. AJR Am J Roentgenol 2001; 176:399-406

176.. Munot K, Dall B, Achuthan R, Parkin G, Lane S, Morgan K. Role of magnetic resonance imagingg in the diagnosis and single-stage surgical resection of invasive lobular carci-nomaa of the breast. Br J Surg 2002; 89:1296-1301

177.. Kneeshaw PJ, Turnbull LW, Smith A, Drew PJ. Dynamic contrast enhanced magnetic resonancee imaging aids the surgical management of invasive lobular breast cancer. Eur JJ Surg Oncol 2003; 29:32-37

178.. Quan ML, Sclafani L, Heerdt AS, Fey JV, Morris EA> Borgen PI. Magnetic resonance imagingg detects unsuspected disease in patients with invasive lobular cancer. Ann Surg Oncoll 2003; 10:1048-1053

179.. Davidson T, Mumtaz H, Hall-Craggs MA, Kissin MW, Thurell W, Taylor I. Impact of Magneticc Resonance Imaging in determining surgical management in breast cancer. Thee Breast 1997;6:177-182

180.. Amano G, Ohuchi N, Ishibashi T, Ishida T, Amari M, Satomi S. Correlation of three-dimensionall magnetic resonance imaging with precise histopathological map concer-ningg carcinoma extension in the breast. Breast Cancer Res Treat 2000; 60:43-55

181.. Egan RL. Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studiess and 10-year survival. Cancer 1982; 49:1123-1130

182.. Ntzani EE, Ioannidis JP. Predictive ability of DNA microarrays for cancer outcomes andd correlates: an empirical assessment. Lancet 2003; 362:1439-1444

183.. Hata T, Takahashi H, Watanabe K, et al. Magnetic resonance imaging for preoperative evaluationn of breast cancer: a comparative study with mammography and ultrasono-graphy.. J Am Coll Surg 2004; 198:190-197

184.. Klein Zeggelink WF, Deurloo EE, Bartelink H, Rutgers EJ, Gilhuijs KG. Reproducibility off the assessment of tumor extent in the breast using multiple image modalities. Med Physs 2003; 30:2919-2926

185.. DeAngelis GA, Moran RE, Fajardo LL, Mugler JP, Christopher JM, Harvey JA. MRI-guidedd needle localization: technique. Semin Ultrasound CT MR 2000; 21:337-350

186.. Viehweg P, Heinig A, Amaya B, Alberich T, Laniado M, Heywang-Kobrunner SH. MR-guidedd interventional breast procedures considering vacuum biopsy in particular. Eur JJ Radiol 2002; 42:32-39

187.. Liberman L, Morris EA, DershawDD, Thornton CM, Van Zee KJ, Tan LK. Fast MRI-Guidedd Vacuum-Assisted Breast Biopsy: Initial Experience. AJR Am J Roentgenol 2003;; 181:1283-1293

188.. Gajdos C, Tartter PI, Bleiweiss I, et al. Mammographic appearance of nonpalpable breastt cancer reflects pathologic characteristics. Ann Surg Oncol 2002; 235:246-251

189.. Beron P, Horwitz E, Martinez A, et al. Pathologic and mammographic findings pre-dictingg the adequacy of tumor excision before breast-conserving therapy. AJR Am J Roentgenoll 1996; 167:1409-1414

190.. Liberman L, Goodstine SL, Dershaw DD, et al. One operation after percutaneous diag-nosiss of nonpalpable breast cancer: frequency and associated factors. AJR Am J Roent-genoll 2002; 178:673-680

References s 159 9

191.. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema fol-lowingg the treatment of breast cancer. Br J Surg 1986; 73:580-584

192.. Shaw JH, Rumball EM. Complications and local recurrence following lymphadenec-tomy.. Br J Surg 1990; 77:760-764

193.. Lotze MT, Duncan MA, Gerber LH, Woltering EA, Rosenberg SA. Early versus delayed shoulderr motion following axillary dissection: a randomized prospective study. Ann Surgg 1981; 193:288-295

194.. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomyy for breast cancer. Ann Surg 1994; 220:391-398

195.. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dis-sectionn in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349:1864-1867 7

196.. Veronesi U, Galimberti V, Zurrida S, et al. Sentinel lymph node biopsy as an indicator forr axillary dissection in early breast cancer. Eur J Cancer 2001; 37:454-458

197.. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomyy without further axillary dissection in patients with sentinel node-negativee breast cancer. J Clin Oncol 2000; 18:2553-2559

198.. de Freitas R, Costa MV, Schneider SV, Nicolau MA, Marussi E. Accuracy of ultrasound andd clinical examination in the diagnosis of axillary lymph node metastases in breast cancer.. Eur J Surg Oncol 1991; 17:240-244

199.. Perre CI, de Hooge P, Leguit P. [Littl e extra information with ultrasonic studies of thee axillary glands in patients with breast carcinoma]. Ned Tijdschr Geneeskd 1991; 135:1275-1277 7

200.. Yang WT, Ahuja A, Tang A, Suen M, King W, Metreweli C. High resolution sonograp-hicc detection of axillary lymph node metastases in breast cancer. J Ultrasound Med 1996;; 15:241-246

201.. Tanis J, van Sandick W, Nieweg E, et al. The hidden sentinel node in breast cancer. Eur JJ Nucl Med 2002; 29:305-311

202.. Feu J, Tresserra F, Fabregas R, et al. Metastatic breast carcinoma in axillary lymph nodes:: in vitro US detection. Radiology 1997; 205:831-835

203.. Vassallo P, Wernecke K, Roos N, Peters PE. Differentiation of benign from malignant superficiall lymphadenopathy: the role of high-resolution US. Radiology 1992; 183:215-220 0

204.. Yang WT, Chang J, Metreweli C. Patients with breast cancer: differences in color Dop-plerr flow and gray- scale US features of benign and malignant axillary lymph nodes. Radiologyy 2000; 215:568-573

205.. Walsh R, Kornguth PJ, Soo MS, Bentley R, DeLong DM. Axillary lymph nodes: mam-mographic,, pathologic, and clinical correlation. AJR Am J Roentgenol 1997; 168:33-38 8

206.. Tschammler A, Ott G, Schang T, Seelbach-Goebel B, Schwager K, Hahn D. Lymphade-nopathy:: differentiation of benign from malignant disease-- color Doppler US assess-mentt of intranodal angioarchitecture. Radiology 1998; 208:117-123

160 0 References s

207.. Yang WT„ Ahuja A, Tang A, Suen M, King W, Metreweli C. Ultrasonographic demon-strationn of normal axillary lymph nodes: a learning curve. J Ultrasound Med 1995; 14:823-827 7

208.. Strauss HG, Lampe D, Methfessel G, Buchmann J. [Preoperative axilla sonography inn breast tumor suspected of malignancy- -a diagnostic advantage?]. Ultraschall Med 1998;; 19:70-77

209.. Gong G. Cross-validation, the Jackknife, and the Bootstrap: Excess Error Estimation in Forwardd Logistic Regression. J Am Stat Assoc 1986; 81:108-113

210.. Uematsu T, Sano M, Homma K. In vitro high-resolution helical CT of small axillary lymphh nodes in patients with breast cancer: correlation of CT and histology. AJR Am J Roentgenoll 2001; 176:1069-1074

211.. Choi MY, Lee JW, Jang KJ. Distinction between benign and malignant causes of cervi-cal,, axillary, and inguinal lymphadenopathy: value of Doppler spectral waveform ana-lysis.. AJR Am J Roentgenol 1995; 165:981-984

212.. Tanis PJ, Nieweg OE, Merkus JW, Peterse JL, Kroon BB. False negative sentinel node proceduree established through palpation of the biopsy wound. Eur J Surg Oncol 2000; 26:714-715 5

213.. Liberman L, Cody HS, III . Percutaneous biopsy and sentinel lymphadenectomy: mini-mallyy invasive diagnosis and treatment of nonpalpable breast cancer. AJR Am J Roent-genoll 2001; 177:887-891

214.. Boolbol SK, Fey JV, Borgen PI, et al. Intradermal isotope injection: a highly accurate methodd of lymphatic mapping in breast carcinoma. Ann Surg Oncol 2001; 8:20-24

215.. Parker SH, Dennis MA, Kaske TL Identification of the sentinel node in patients with breastt cancer. Radiol Clin North Am 2000; 38:809-823

216.. Liberman L. Centennial dissertation. Percutaneous imaging-guided core breast biopsy: statee of the art at the millennium. AJR Am J Roentgenol 2000; 174:1191-1199

217.. Reynolds HE, Poon CM, Goulet RJ, Lazaridis CL. Biopsy of breast microcalcifications usingg an 11-gauge directional vacuum-assisted device. AJR Am J Roentgenol 1998; 171:611-613 3

218.. Schnall MD, Rosten S, Englander S, Orel SG, Nunes LW. A combined architectural and kineticc interpretation model for breast MR images. Acad Radiol 2001; 8:591-597

219.. Wedegartner U, Bick U, Wortler K, Rummeny E, Bongartz G. Differentiation between benignn and malignant findings on MR- mammography: usefulness of morphological criteria.. Eur Radiol 2001; 11:1645-1650

220.. Abdolmaleki P, Buadu LD, Naderimansh H. Feature extraction and classification of breastt cancer on dynamic magnetic resonance imaging using artificial neural network. Cancerr Lett 2001; 171:183-191

221.. Shahar KH, Solaiyappan M, Bluemke DA. Quantitative differentiation of breast lesions basedd on three- dimensional morphology from magnetic resonance imaging. J Comput Assistt Tomogr 2002; 26:1047-1053

222.. Lucht R, Delorme S, Brix G. Neural network-based segmentation of dynamic MR mammographicc images. Magn Reson Imaging 2002; 20:147-154

References s 161 1

223.. Jacobs MA, Barker PB, Bluemke DA, et al. Benign and malignant breast lesions: diag-nosiss with multiparametric MR imaging. Radiology 2003; 229:225-232

224.. Gibbs P, Turnbull LW. Textural analysis of contrast-enhanced MR images of the breast. Magnn Reson Med 2003; 50:92-98

225.. Kelcz F, Furman-Haran E, Grobgeld D, Degani H. Clinical testing of high-spatial-reso-lutionn parametric contrast-enhanced MR imaging of the breast. AJR Am J Roentgenol 2002;; 179:1485-1492

226.. Yang WT, Lam WW, Cheung H, Suen M, King WW, Metreweli C. Sonographic, magne-ticc resonance imaging, and mammographic assessments of preoperative size of breast cancer.. J Ultrasound Med 1997; 16:791-797

227.. Turnbull LW, Barker S, Liney GP. Comparative effectiveness of magnetic resonance imagingg in breast cancer (COMICE trial). Breast Cancer Res.Treat. 2002; 4[(Suppl. 1)]: 39. .

228.. Kvistad KA, Rydland J, Smethurst HB, Lundgren S, Fjosne HE, Haraldseth O. Axillary lymphh node metastases in breast cancer: preoperative detection with dynamic contrast-enhancedd MRL Eur Radiol 2000; 10:1464-1471

229.. Murray AD, Staff RT, Redpath TW, et al. Dynamic contrast enhanced MRI of the axilla inn women with breast cancer: comparison with pathology of excised nodes. Br J Radiol 2002;; 75:220-228

230.. Suzuma T, Sakurai T, Yoshimura G, et al. MR-axillography oriented surgical sampling forr assessment of nodal status in the selection of patients with breast cancer for axillary lymphh nodes dissection. Breast Cancer 2002; 9:69-74

231.. Suga K, Yuan Y, Ogasawara N, Okada M, Matsunaga N. Localization of breast sentinel lymphh nodes by MR lymphography with a conventional gadolinium contrast agent. Preliminaryy observations in dogs and humans. Acta Radiol 2003; 44:35-42

232.. Michel SC, Keller TM, Frohlich JM, et al. Preoperative breast cancer staging: MR ima-gingg of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radio-logyy 2002; 225:527-536

233.. Stets C, Brandt S, Wallis F, Buchmann J, Gilbert FJ, Heywang-Kobrunner SH. Axillary lymphh node metastases: a statistical analysis of various parameters in MRI with USPIO. JJ Magn Reson Imaging 2002; 16:60-68

234.. Kuenen-Boumeester V, Menke-Pluymers M, de Kanter AY, Obdeijn IM, Urich D, Van Derr Kwast TH. Ultrasound-guided fine needle aspiration cytology of axillary lymph nodess in breast cancer patients. A preoperative staging procedure. Eur J Cancer 2003; 39:170-174 4

235.. de Kanter AY, van Geel AN, Paul MA, et al. Controlled introduction of the sentinel nodee biopsy in breast cancer in a multi-centre setting: the role of a coordinator for qualityy control. Eur J Surg Oncol 2000; 26:652-656

236.. Oruwari JU, Chung MA, Koelliker S, Steinhoff MM, Cady B. Axillary staging using ultrasound-guidedd fine needle aspiration biopsy in locally advanced breast cancer. Am JJ Surg 2002; 184:307-309

162 2 References s

237.. Damera A, Evans AJ, Cornford EJ, et al. Diagnosis of axillary nodal metastases by ultrasound-guidedd core biopsy in primary operable breast cancer. Br J Cancer 2003; 89:1310-1313 3

238.. Sapino A, Cassoni P, Zanon E, et al. Ultrasonographically-guided fine-needle aspira-tionn of axillary lymph nodes: role in breast cancer management. Br J Cancer 2003; 88:702-706 6

239.. Yang WT, Metreweli C, Lam PK, Chang J. Benign and malignant breast masses and axillaryy nodes: evaluation with echo-enhanced color power Doppler US. Radiology 2001;220:795-802 2

240.. Wahl RL, Siegel BA, Coleman RE, Gatsonis CG. Prospective Multicenter Study of Axil -laryy Nodal Staging by Positron Emission Tomography in Breast Cancer: A Report of thee Staging Breast Cancer With PET Study Group. J Clin Oncol 2004; 22:277-285

241.. Barranger E, Grahek D, Antoine M, Montravers F, Talbot JN, Uzan S. Evaluation of fluorodeoxyglucosee positron emission tomography in the detection of axillary lymph nodee metastases in patients with early-stage breast cancer. Ann Surg Oncol 2003; 10:622-627 7

242.. Spanu A, Dettori G, Chiaramida P, et al. The role of 99mTc-tetrofosmin Pinhole-SPECT inn breast cancer axillary lymph node staging. Cancer Biother Radiopharm 2000; 15:81-91 1

243.. Shimizu T, Hino K, Tauchi K, Ansai Y, Tsukada K. Predication of axillary lymph node metastasiss by intravenous digital subtraction angiography in breast cancer, its correla-tionn with microvascular density. Breast Cancer Res Treat 2000; 61:261-269

244.. Bedrosian I, Bedi D, Kuerer HM, et al. Impact of clinicopathological factors on sensiti-vityy of axillary ultrasonography in the detection of axillary nodal metastases in patients withh breast cancer. Ann Surg Oncol 2003; 10:1025-1030

245.. Cornford E, Evans A. Editorial comment on «Reduction in the number of sentinel lymphh node procedures by preoperative ultrasonography of the axilla in breast cancer» byy Deurloo and colleagues. Eur J Cancer 2003; 39:1037-1038

246.. Holland R, Hendriks JH, Vebeek AL, Mravunac M, Schuurmans Stekhoven JH. Extent, distribution,, and mammographic/histological correlations of breast ductal carcinoma inn situ. Lancet 1990; 335:519-522

247.. Cleverley JR, Jackson AR, Bateman AC. Pre-operative localization of breast microcal-cificationn using high- frequency ultrasound. Clin Radiol 1997; 52:924-926

248.. Tamaki Y, Akashi-Tanaka S, Ishida T, et al. 3D Imaging of Intraductal Spread of Breast Cancerr and Its Clinical Application for Navigation Surgery. Breast Cancer 2002; 9:289-295 5

249.. Soderstrom CE, Harms SE, Farrell RS, Jr., Pruneda JM, Flamig DP. Detection with MR imagingg of residual tumor in the breast soon after surgery. AJR Am J Roentgenol 1997; 168:485-488 8

250.. Viehweg P, Lampe D, Buchmann J, Heywang-Kobrunner SH. In situ and minimally invasivee breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.. MAGM A 2000; 11:129-137

References s 163 3

251.. Mullen DJ, Eisen RN, Newman RD, Perrone PM, Wilsey JC. The use of carbon marking afterr stereotactic large-core-needle breast biopsy. Radiology 2001; 218:255-260

252.. Rahusen FD, Bremers AJ, Fabry HF, van Amerongen AH, Boom RP, Meijer S. Ultrasound-guidedd lumpectomy of nonpalpable breast cancer versus wire- guided resection:: a randomized clinical trial. Ann Surg Oncol 2002; 9:994-998

253.. Sato Y, Nakamoto M, Tamaki Y, et al. Image guidance of breast cancer surgery using 3-DD ultrasound images and augmented reality visualization. IEEE Trans Med Imaging 1998;; 17:681-693

254.. Tamaki Y, Sato Y, Nakamoto M, et al. Intraoperative navigation for breast cancer sur-geryy using 3D ultrasound images. Comput Aided Surg 1999; 4:37-44

255.. Hirose M, Kacher DF, Smith DN, Kaelin CM, Jolesz FA. Feasibility of MR imaging-guidedd breast lumpectomy for malignant tumors in a 0.5-T open-configuration MR imagingg system. Acad Radiol 2002; 9:933-941